Published in J Exp Med on February 01, 1994
Costimulatory molecule-deficient dendritic cell progenitors (MHC class II+, CD80dim, CD86-) prolong cardiac allograft survival in nonimmunosuppressed recipients. Transplantation (1996) 1.86
Bone marrow-derived dendritic cell progenitors (NLDC 145+, MHC class II+, B7-1dim, B7-2-) induce alloantigen-specific hyporesponsiveness in murine T lymphocytes. Transplantation (1995) 1.63
Alloantigen priming induces a state of unresponsiveness in human umbilical cord blood T cells. Proc Natl Acad Sci U S A (1995) 0.91
T cell apoptosis in human heart allografts: association with lack of co-stimulation? Am J Pathol (1998) 0.81
T-cell anergy induced by clonotype-specific antibodies: modulation of an autoreactive human T-cell clone in vitro. Immunology (1999) 0.76
Blocking B7 and CD40 co-stimulatory molecules decreases antiviral T cell activity. Clin Exp Immunol (2004) 0.75
A cell culture model for T lymphocyte clonal anergy. Science (1990) 9.86
Regulation of lymphokine messenger RNA stability by a surface-mediated T cell activation pathway. Science (1989) 7.78
CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones. Nature (1992) 7.15
Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy. Cell (1992) 5.67
The role of the CD28 receptor during T cell responses to antigen. Annu Rev Immunol (1993) 5.65
Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo. J Exp Med (1987) 5.48
Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4lg. Science (1992) 5.36
Regulation of interleukin-2 gene enhancer activity by the T cell accessory molecule CD28. Science (1991) 5.12
CD28 activation pathway regulates the production of multiple T-cell-derived lymphokines/cytokines. Proc Natl Acad Sci U S A (1989) 5.07
T-cell proliferation involving the CD28 pathway is associated with cyclosporine-resistant interleukin 2 gene expression. Mol Cell Biol (1987) 4.76
B70 antigen is a second ligand for CTLA-4 and CD28. Nature (1993) 3.57
T-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo. Proc Natl Acad Sci U S A (1992) 2.98
Induction of alloantigen-specific hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7/BB1. J Exp Med (1993) 2.71
Molecular events in the induction of a nonresponsive state in interleukin 2-producing helper T-lymphocyte clones. Proc Natl Acad Sci U S A (1987) 2.57
Allogeneic non-T spleen cells restore the responsiveness of normal T cell clones stimulated with antigen and chemically modified antigen-presenting cells. J Immunol (1988) 2.48
CD28 ligation in T-cell activation: evidence for two signal transduction pathways. Blood (1990) 2.21
Activation of interleukin-2 gene transcription via the T-cell surface molecule CD28 is mediated through an NF-kB-like response element. J Biol Chem (1991) 1.92
Leukocyte function-associated antigen 1 is an activation molecule for human T cells. J Exp Med (1989) 1.69
Split anergy in a CD8+ T cell: receptor-dependent cytolysis in the absence of interleukin-2 production. Science (1991) 1.61
Transmembrane signalling via the T11-dependent pathway of human T cell activation. Evidence for the involvement of 1,2-diacylglycerol and inositol phosphates. Eur J Immunol (1987) 1.49
Roles of multiple accessory molecules in T-cell activation. Curr Opin Immunol (1991) 1.48
Antibody and B7/BB1-mediated ligation of the CD28 receptor induces tyrosine phosphorylation in human T cells. J Exp Med (1992) 1.44
Anergic Th1 cells express altered levels of the protein tyrosine kinases p56lck and p59fyn. J Immunol (1992) 1.15
In situ expression of B7/BB1 on antigen-presenting cells and activated B cells: an immunohistochemical study. Int Immunol (1993) 1.04
More exact quantification of interleukin-2 production by addition of anti-Tac monoclonal antibody to cultures of stimulated lymphocytes. J Immunol Methods (1987) 0.99
Anergized T cell clones retain their cytolytic ability. J Immunol (1993) 0.98
FK-506 and cyclosporin A: immunosuppressive mechanism of action and beyond. Curr Opin Immunol (1992) 0.94
Functional characterization of a novel anti-B7 monoclonal antibody. Eur J Immunol (1992) 0.94
CD28 ligation by monoclonal antibodies or B7/BB1 provides an accessory signal for the cyclosporin A-resistant generation of cytotoxic T cell activity. J Immunol (1993) 0.91
The influence of cyclosporin A on the alternative pathways of human T cell activation in vitro. Eur J Immunol (1989) 0.84
Mutations in the X-linked and autosomal recessive forms of chronic granulomatous disease. Blood (1996) 2.27
Multicenter evaluation of the Cepheid Xpert methicillin-resistant Staphylococcus aureus (MRSA) test as a rapid screening method for detection of MRSA in nares. J Clin Microbiol (2009) 2.20
The epidemiology of HIV and syphilis among male commercial sex workers in northern Thailand. AIDS (1995) 2.12
Meconium-stained amniotic fluid: discharge vigorous newborns. Arch Dis Child Fetal Neonatal Ed (2009) 2.04
Interleukin-10 inhibits B7 and intercellular adhesion molecule-1 expression on human monocytes. Eur J Immunol (1994) 2.04
[Management and choice of antibiotics for patients with an allergy to penicillin]. Ned Tijdschr Geneeskd (1999) 2.02
Human dendritic cells require exogenous interleukin-12-inducing factors to direct the development of naive T-helper cells toward the Th1 phenotype. Blood (1997) 1.82
TTRAP, a novel protein that associates with CD40, tumor necrosis factor (TNF) receptor-75 and TNF receptor-associated factors (TRAFs), and that inhibits nuclear factor-kappa B activation. J Biol Chem (2000) 1.67
Eosinophilic rhinitis accompanies the development of lower airway inflammation and hyper-reactivity in sensitized mice exposed to aerosolized allergen. Clin Exp Allergy (2001) 1.60
CD80, CD86 and CD40 provide accessory signals in a multiple-step T-cell activation model. Immunol Rev (1996) 1.60
Early skeletal muscle hypertrophy and architectural changes in response to high-intensity resistance training. J Appl Physiol (1985) (2006) 1.59
Purification and cryopreservation of phagocytes from human blood. Methods Enzymol (1986) 1.58
Type III IFN-lambda mRNA expression in sputum of adult and school-aged asthmatics. Clin Exp Allergy (2008) 1.56
Monoclonal antibodies to the CD5 antigen can provide the necessary second signal for activation of isolated resting T cells by solid-phase-bound OKT3. J Immunol (1986) 1.52
Interaction between human neutrophils and zymosan particles: the role of opsonins and divalent cations. J Immunol (1981) 1.51
Leukocyte adhesion deficiency type 1 (LAD-1)/variant. A novel immunodeficiency syndrome characterized by dysfunctional beta2 integrins. J Clin Invest (1997) 1.51
Differential changes in heat shock protein-, lipoarabinomannan-, and purified protein derivative-specific immunoglobulin G1 and G2 isotype responses during bovine Mycobacterium avium subsp. paratuberculosis infection. Infect Immun (2001) 1.50
Evaluation of airway inflammation by quantitative Th1/Th2 cytokine mRNA measurement in sputum of asthma patients. Thorax (2006) 1.50
IL-15 is highly expressed in inflammatory bowel disease and regulates local T cell-dependent cytokine production. J Immunol (2000) 1.45
Adalimumab induces apoptosis of human monocytes: a comparative study with infliximab and etanercept. Aliment Pharmacol Ther (2005) 1.45
A highly sensitive assay for detection and quantitation of human cytomegalovirus DNA in serum and plasma by PCR and electrochemiluminescence. J Clin Microbiol (1999) 1.43
Increased cytolytic T lymphocyte activity and decreased B7 responsiveness are associated with CD28 down-regulation on CD8+ T cells from HIV-infected subjects. Clin Exp Immunol (1995) 1.40
B7/CD28-dependent IL-5 production by human resting T cells is inhibited by IL-10. J Immunol (1994) 1.33
Haptoglobin directly affects T cells and suppresses T helper cell type 2 cytokine release. Immunology (2003) 1.31
Ligation of B7 with CD28/CTLA-4 on T cells results in CD40 ligand expression, interleukin-4 secretion and efficient help for antibody production by B cells. Eur J Immunol (1993) 1.29
Decreased expression of the memory marker CD26 on both CD4+ and CD8+ T lymphocytes of HIV-infected subjects. J Acquir Immune Defic Syndr (1993) 1.29
Alveolar T-cell subsets in pulmonary sarcoidosis. Correlation with disease activity and effect of steroid treatment. Am Rev Respir Dis (1984) 1.26
Transcriptional regulation of the Saccharomyces cerevisiae amino acid permease gene BAP2. Mol Gen Genet (2001) 1.24
Flow cytometric measurement of cytoplasmic free calcium in human peripheral blood T lymphocytes with fluo-3, a new fluorescent calcium indicator. J Immunol Methods (1990) 1.23
Hyperexpression of CD40 ligand (CD154) in inflammatory bowel disease and its contribution to pathogenic cytokine production. J Immunol (1999) 1.20
T cell unresponsiveness to the mitogenic activity of OKT3 antibody results from a deficiency of monocyte Fc gamma receptors for murine IgG2a and inability to cross-link the T3-Ti complex. J Immunol (1985) 1.19
Anti-Ia reactivity in sera from patients with systemic lupus erythematosus. J Clin Invest (1982) 1.19
Immune dysfunction in patients with functional gastrointestinal disorders. Neurogastroenterol Motil (2008) 1.18
A point mutation in gp91-phox of cytochrome b558 of the human NADPH oxidase leading to defective translocation of the cytosolic proteins p47-phox and p67-phox. J Clin Invest (1994) 1.18
Prevention of experimental colitis in SCID mice reconstituted with CD45RBhigh CD4+ T cells by blocking the CD40-CD154 interactions. J Immunol (2000) 1.17
Point mutations in the beta-subunit of cytochrome b558 leading to X-linked chronic granulomatous disease. Blood (1991) 1.17
Anaerobic degradation of halogenated benzoic acids by photoheterotrophic bacteria. FEMS Microbiol Lett (1994) 1.15
Subset markers of CD8(+) cells and their relation to enhanced cytotoxic T-cell activity during human immunodeficiency virus infection. J Clin Immunol (1991) 1.15
Molecular diagnosis of chronic granulomatous disease. Clin Exp Immunol (2014) 1.14
Cytochrome b deficiency in an autosomal form of chronic granulomatous disease. A third form of chronic granulomatous disease recognized by monocyte hybridization. J Clin Invest (1985) 1.14
Identification of haptoglobin as an alternative ligand for CD11b/CD18. J Immunol (1996) 1.13
Ligation of the CD5 or CD28 molecules on resting human T cells induces expression of the early activation antigen CD69 by a calcium- and tyrosine kinase-dependent mechanism. Immunology (1993) 1.10
Phase I trial of ZD1694, a new folate-based thymidylate synthase inhibitor, in patients with solid tumors. J Clin Oncol (1996) 1.10
Involvement of 4-1BB (CD137)-4-1BBligand interaction in the modulation of CD4 T cell-mediated inflammatory colitis. Clin Exp Immunol (2006) 1.09
Metabolic comparison between basophils and other leukocytes from human blood. J Immunol (1986) 1.09
Complementation in monocyte hybrids revealing genetic heterogeneity in chronic granulomatous disease. Nature (1984) 1.08
Regulation of immunoglobulin production in pokeweed mitogen-stimulated cultures of lymphocytes from young and old adults. J Immunol (1982) 1.07
Regulation of glycerol kinase by enzyme IIIGlc of the phosphoenolpyruvate:carbohydrate phosphotransferase system. J Bacteriol (1986) 1.06
Expression patterns of Fc gamma receptors, HLA-DR and selected adhesion molecules on monocytes from normal and HIV-infected individuals. Clin Exp Immunol (1994) 1.06
Decreased CD40 ligand induction in CD4 T cells and dysregulated IL-12 production during HIV infection. Clin Exp Immunol (1999) 1.05
Immunologic detection of endothelial cells in human whole blood. Blood (1991) 1.05
Role of interleukin-12 in the induction of mucosal inflammation and abrogation of regulatory T cell function in chronic experimental colitis. Eur J Immunol (2001) 1.05
Sports injuries in New Zealand. N Z Med J (1986) 1.05
Measurement of serum cytokine levels in patients with myelodysplastic syndromes. Leukemia (1992) 1.05
Phenotype, cytokine production and cytolytic capacity of fresh (uncultured) tumour-infiltrating T lymphocytes in human renal cell carcinoma. Clin Exp Immunol (1997) 1.05
In situ expression of B7/BB1 on antigen-presenting cells and activated B cells: an immunohistochemical study. Int Immunol (1993) 1.04
B7 interactions with CD28 and CTLA-4 control tolerance or induction of mucosal inflammation in chronic experimental colitis. J Immunol (2001) 1.03
Professional presentation of antigen by activated human T cells. Eur J Immunol (1994) 1.03
Specific leukotriene formation by purified human eosinophils and neutrophils. FEBS Lett (1984) 1.03
Changes in IgG Fc receptor expression induced by phorbol 12-myristate 13-acetate treatment of THP-1 monocytic leukemia cells. Leuk Res (1992) 1.03
The anti-T cell monoclonal antibody 9.3 (anti-CD28) provides a helper signal and bypasses the need for accessory cells in T cell activation with immobilized anti-CD3 and mitogens. Cell Immunol (1989) 1.03
Openness to discuss cancer in the nuclear family: scale, development, and validation. Psychosom Med (1997) 1.02
Risk factors for HIV-1 transmission from HIV-seropositive male blood donors to their regular female partners in northern Thailand. AIDS (1997) 1.02
CD57+/CD28- T cells in untreated hemato-oncological patients are expanded and display a Th1-type cytokine secretion profile, ex vivo cytolytic activity and enhanced tendency to apoptosis. Leukemia (1998) 1.02
Progesterone increases airway eosinophilia and hyper-responsiveness in a murine model of allergic asthma. Clin Exp Allergy (2003) 1.01
Cooperation between an anti-T cell (anti-CD28) monoclonal antibody and monocyte-produced IL-6 in the induction of T cell responsiveness to IL-2. J Immunol (1988) 1.01
Defective host defence mechanisms in a family with hypocalciuric hypercalcaemia and coexisting interstitial lung disease. Clin Exp Immunol (1985) 1.01
Stem cell factor as a novel diagnostic marker for early malignant germ cells. J Pathol (2008) 1.00
Tumor necrosis factor-alpha and interleukin 6 synergistically induce T cell growth. Eur J Immunol (1990) 1.00
Simultaneous ligation of CD5 and CD28 on resting T lymphocytes induces T cell activation in the absence of T cell receptor/CD3 occupancy. J Immunol (1993) 0.99
More exact quantification of interleukin-2 production by addition of anti-Tac monoclonal antibody to cultures of stimulated lymphocytes. J Immunol Methods (1987) 0.99
Accessory signaling by CD40 for T cell activation: induction of Th1 and Th2 cytokines and synergy with interleukin-12 for interferon-gamma production. Eur J Immunol (1996) 0.98
Depressed T-cell reactivity to recall antigens in rheumatoid arthritis. J Clin Immunol (1990) 0.97
Effects of anti-IL-4 receptor monoclonal antibody on in vitro T cell cytokine levels: IL-4 production by T cells from non-atopic donors. Clin Exp Immunol (1998) 0.97
Staphylococcus aureus enterotoxin B facilitates allergic sensitization in experimental asthma. Clin Exp Allergy (2010) 0.97
IL-12 up-regulates CD40 ligand (CD154) expression on human T cells. J Immunol (1998) 0.97
Mucosal expression by B7-positive cells of the 60-kilodalton heat-shock protein in inflammatory bowel disease. Gastroenterology (1995) 0.96
Impact of lipoteichoic acid modification on the performance of the probiotic Lactobacillus rhamnosus GG in experimental colitis. Clin Exp Immunol (2010) 0.96
Sinonasal pathology in nonallergic asthma and COPD: 'united airway disease' beyond the scope of allergy. Allergy (2007) 0.96
The presence of Ia antigen on human peripheral blood T cells and T-cell subsets: analysis with monoclonal antibodies and the fluorescence-activated cell sorter. Cell Immunol (1981) 0.96
Confirmation of self-report of HIV testing among a cohort of pregnant women. J Clin Epidemiol (1997) 0.96
Different circulating lymphocyte profiles in patients with different subtypes of juvenile idiopathic arthritis. Clin Exp Rheumatol (2002) 0.95
Differences in the stimulating capacity of immobilized anti-CD3 monoclonal antibodies: variable dependence on interleukin-1 as a helper signal for T-cell activation. Immunology (1991) 0.95
Gene-scan method for the recognition of carriers and patients with p47(phox)-deficient autosomal recessive chronic granulomatous disease. Exp Hematol (2001) 0.95
The B7/BB1 antigen is expressed by Reed-Sternberg cells of Hodgkin's disease and contributes to the stimulating capacity of Hodgkin's disease-derived cell lines. Blood (1993) 0.95
Interaction of CTLA-4 (CD152) with CD80 or CD86 inhibits human T-cell activation. Immunology (1999) 0.95
CD8+ cells and not CD4+ T cells are hyporesponsive to CD28- and CD40L-mediated activation in HIV-infected subjects. Clin Exp Immunol (1997) 0.94
IL-6 is an accessory signal in the alternative CD2-mediated pathway of T cell activation. J Immunol (1990) 0.94
Sputum cytokine mapping reveals an 'IL-5, IL-17A, IL-25-high' pattern associated with poorly controlled asthma. Clin Exp Allergy (2013) 0.94